Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ambarella Inc (AMBA) vs GSK plc (GSK) Price & Performance

Ambarella IncTrade

Price performance (Past 24H)

Key statistics

Ambarella Inc vs GSK plc — how do they compare? Ambarella Inc trades at $84.08 (market cap $3.64B), while GSK plc trades at $50.58 (market cap $102.60B). The key difference: GSK plc is far larger — about 28.2× Ambarella Inc's market cap, and GSK plc pays a 3.57% dividend while Ambarella Inc pays none. Which is the better fit depends on your goals.

AMBAGSK
Market Cap
$3.64B$102.60B
Sector
TechnologyHealth
52-Week High
$95.51$61.18
52-Week Low
$48.65$38.22
Enterprise Value
$3.37B$123.04B
Dividend Yield
3.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ambarella Inc

Ambarella (AMBA) trades at $86.78, up 3.57% with strong technical momentum. The stock shows bullish moving average signals despite negative profitability metrics. Recent news highlights NXP's potential acquisition interest and the company's strategic pivot to edge AI chips, driving analyst optimism. Q2 2026 earnings are expected at $0.171 per share, following three consecutive quarterly beats. Revenue growth is projected to accelerate from $285M in 2025 to $405M in 2026.

Outlook remains positive with 58% analyst buy ratings and $108.67 price target, but risks include persistent net losses, high valuation multiples, and competitive pressure in semiconductor space. The edge AI transition offers growth potential, yet execution risks and insider selling warrant caution for investors.

GSK plc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ambarella Inc

Ambarella is a semiconductor company specializing in low-power video compression and computer vision processors. Its chips power AI cameras for security, automotive safety, and robotics applications.

Read more on AMBA

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK